Clinical Trials Directory

Trials / Completed

CompletedNCT04448821

A Clinical Trial to Evaluate the Effect of Nilotinib on the PK/PD of Meformin

A Clinical Trial to Evaluate the Effect of Nilotinib on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Male Adults

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Hyewon Chung · Academic / Other
Sex
Male
Age
19 Years – 50 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to evaluate the effect of nilotinib on the pharmacokinetics and pharmacodynamics of metformin in healthy male adults

Detailed description

Pharmacokinetics and pharmacodynamics of metformin without coadministration of nilotinib will be compared with those after administration of nilotinib.

Conditions

Interventions

TypeNameDescription
DRUGMetforminSingle administration of metformin
DRUGMetformin + NilotinibCoadministration of metformin and nilotinib

Timeline

Start date
2020-07-23
Primary completion
2020-09-07
Completion
2020-09-07
First posted
2020-06-26
Last updated
2020-11-04

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04448821. Inclusion in this directory is not an endorsement.

A Clinical Trial to Evaluate the Effect of Nilotinib on the PK/PD of Meformin (NCT04448821) · Clinical Trials Directory